EQS-News: Epigenomics AG / Key word(s): Contract/DisposalEpigenomics AG Announces Closing of Agreement on the Acquisition of Almost All of the Company's Assets and Adjustment of Guidance for 2023 10.10.2023 / 21:10 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG Announces Closing of Agreement on the Acquisition of Almost All of […]
Category: Press Releases
10. October 2023
Epigenomics AG Announces Closing of Agreement on the Acquisition of Almost All of the Company’s Assets and Adjustment of Guidance for 2023
Read more
05. September 2023
Epigenomics AG: Pareto and Warburg publish analyst research reports
EQS-News: Epigenomics AG / Key word(s): Research UpdateEpigenomics AG: Pareto and Warburg publish analyst research reports 05.09.2023 / 17:20 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG: Pareto and Warburg publish analyst research reports Analysts consider acceptance of New Day Diagnostics’ purchase offer advantageous for shareholders Buy recommendation with price […]
10. August 2023
Epigenomics AG publishes financial results for the first six months 2023
EQS-News: Epigenomics AG / Key word(s): Half Year Report/Half Year ResultsEpigenomics AG publishes financial results for the first six months 2023 10.08.2023 / 08:00 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG publishes financial results for the first six months 2023 Berlin (Germany), August 10, 2023 – Epigenomics AG (FSE: […]
24. July 2023
Epigenomics AG Announces Successful Agreement on the Acquisition of Significant Assets
EQS-News: Epigenomics AG / Key word(s): Strategic Company Decision/ContractEpigenomics AG Announces Successful Agreement on the Acquisition of Significant Assets 24.07.2023 / 18:40 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG Announces Successful Agreement on the Acquisition of Significant Assets Acquirer is U.S. full-service diagnostics and CRO services company New Day […]
31. May 2023
Epigenomics AG Reports Financial Results for the First Quarter of 2023
EQS-News: Epigenomics AG / Key word(s): Quarterly / Interim Statement/Quarter ResultsEpigenomics AG Reports Financial Results for the First Quarter of 2023 31.05.2023 / 08:00 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG Reports Financial Results for the First Quarter of 2023 Berlin (Germany) and San Diego, CA (USA), May 31, […]
19. May 2023
Epigenomics AG: Member of the Executive Board and Chief Scientific Officer Andrew Lukowiak Resigns
EQS-News: Epigenomics AG / Key word(s): Personnel/MiscellaneousEpigenomics AG: Member of the Executive Board and Chief Scientific Officer Andrew Lukowiak Resigns 19.05.2023 / 18:00 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG: Member of the Executive Board and Chief Scientific Officer Andrew Lukowiak Resigns Berlin (Germany), May 19, 2023 -The Member […]